Abstract
Limited data are available concerning supraventricular tachycardia (SVT) recurrence. Hence, this study aimed to determine the incidence, outcome, and factors associated with SVT recurrence. This retrospective, observational, population-based study was conducted among children with SVT from 2006 to 2020. The primary outcome measure was SVT recurrence. Kaplan Meier analysis was used to estimate SVT-free at 1, 5, and 10 years after diagnosis. Cox regression analysis was used to identify independent factors associated with recurrence. There were 156 patients with SVT with a median age at diagnosis of 1.9 years (Interquartile range [IQR] 11 days to 8.7 years) and follow-up for a median of 3.5 years (IQR 1.7 to 6.1 years). 35 patients (22%) had recurrent SVT at a median age of 7.8 years (IQR 4.4 to 12 years). Infants with Wolff-Parkinson-White Syndrome (WPW) had the highest recurrence (11/16, 68%), with 33% SVT-free at 5 years follow-up. The lowest recurrence rate was observed in neonatal diagnosis (2/54, 3.7%) with 98% SVT-free at 5 years follow-up. The independent factors associated with the recurrence of SVT were the diagnosis of WPW with an adjusted hazard ratio (aHR) of 5.2 (95% CI 2.4–11.2), age of more than 1 year at diagnosis (aHR 3.7 95% CI 1.4–9.7), and combine with or need second-line therapy (aHR 4.0 95% CI 1.5–10.7). One in five children with SVT experienced a recurrence, which is more likely for those with WPW, multiple maintenance therapy, and older age at first presentation. Whereas neonates with non-WPW may benefit from shorter maintenance therapy.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Turner CJ, Wren C (2013) The epidemiology of arrhythmia in infants: a population-based study. J Paediatr Child Health 49:278–281. https://doi.org/10.1111/jpc.12155
Perry JC, Garson A (1990) Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 16:1215–1220. https://doi.org/10.1016/0735-1097(90)90555-4
Tortoriello TA, Snyder CS, Smith EOB, Fenrich AL, Friedman RA, Kertesz NJ (2003) Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propranolol therapy. Am J Cardiol 92:1045–1049. https://doi.org/10.1016/j.amjcard.2003.06.002
Deal BJ, Keane JF, Gillette PC, Garson A (1985) Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 5:130–135. https://doi.org/10.1016/S0735-1097(85)80095-4
Capponi G, Belli G, Giovannini M, Remaschi G, Brambilla A, Vannuccini F, Favili S, Porcedda G, De Simone L (2021) Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre. BMC Cardiovasc Disord 21:137. https://doi.org/10.1186/s12872-020-01843-0
Wu M-H, Chang Y-C, Lin J-L, Young ML, Wang JK, Lue HC (1994) Probability of supraventricular tachycardia recurrence in pediatric patients. Cardiology 85:284–289
Aljohani OA, Herrick NL, Borquez AA, Shepard S, Perry JC, Williams MR (2021) Antiarrhythmic treatment duration and tachycardia recurrence in infants with supraventricular tachycardia. Pediatr Cardiol 42:716–720. https://doi.org/10.1007/s00246-020-02534-5
Mecklin M, Linnanmäki A, Hiippala A, Leino T, Arola A, Leskinen M et al (2023) Multicenter cohort study on duration of antiarrhythmic medication for supraventricular tachycardia in infants. Eur J Pediatr 182:1089–1097. https://doi.org/10.1007/s00431-022-04757-5
Moore JA, Stephens SB, Kertesz NJ, Evans DL, Kim JJ, Howard TS et al (2022) Clinical predictors of recurrent supraventricular tachycardia in infancy. J Am Coll Cardiol 80:1159–1172. https://doi.org/10.1016/j.jacc.2022.06.038
Mat Bah MN, Sapian MH, Jamil MT, Abdullah N, Alias EY, Zahari N (2018) The birth prevalence, severity, and temporal trends of congenital heart disease in the middle-income country: a population-based study. Congenit Heart Dis 13:1012–1027. https://doi.org/10.1111/chd.12672
Kothari DS, Skinner JR (2006) Neonatal tachycardias: an update. Arch Dis Child Fetal Neonatal. https://doi.org/10.1136/adc.2004.049049
Granada J, Uribe W, Chyou P-H, Maassen K, Vierkant R, Smith PN et al (2000) Incidence and Predictors of Atrial Flutter in the General Population. J Am Coll Cardiol 36:2242–2246
Lewis J, Arora G, Tudorascu DL, Hickey RW, Saladino RA, Manole MD (2017) Acute management of refractory and unstable pediatric supraventricular tachycardia. J Pediatr 181:177–182. https://doi.org/10.1016/j.jpeds
Sanatani S, Hamilton RM, Gross GJ (2002) Predictors of refractory tachycardia in infants with supraventricular tachycardia. Pediatr Cardiol 23:508–512. https://doi.org/10.1007/s00246-002-1514-4
Riggs TW, Byrd JA, Weinhouse E (1999) Recurrence risk of supraventricular tachycardia in pediatric patients. Cardiology 91:25–30
Acknowledgements
We thank the Director-General of Health Malaysia for permission to publish this article.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. BKP, MHS, NZ, and MNMB performed material preparation, data collection, and analysis. MNMB wrote the first draft of the manuscript, and all authors commented on previous versions. Finally, all authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics Approval
All procedures performed in studies involving human participants followed the clinical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Medical Research and Ethics Committee, Ministry of Health, Malaysia [ID No: NMRR-22-00048-LM0 (IIR)].
Consent to Participate
Informed consent was waived from all individual participants in the study due to the nature of the study by the Medical Research and Ethics Committee.
Consent to Publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bah, M.N.M., Zahari, N., Boparam, B.K. et al. The Incidence and Factors Associated with the Recurrence of Supraventricular Tachycardia in Children: 15 Years Experience from Middle-Income Country. Pediatr Cardiol 45, 292–299 (2024). https://doi.org/10.1007/s00246-023-03374-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-023-03374-9